S&P 500 Health Care Index gains 0.1% The S&P 500 Health Care Index rose 0.1%, underperforming the Nasdaq, S&P 500, and Dow. Pfizer's $10.5B oncology pact with Innovent strengthens its access to early-stage therapies. France's reimbursement for Novo Nordisk's an
S&P 500 Health Care Index gains 0.1%
The S&P 500 Health Care Index rose 0.1%, underperforming the Nasdaq, S&P 500, and Dow.
Pfizer’s $10.5B oncology pact with Innovent strengthens its access to early-stage therapies.
France’s reimbursement for Novo Nordisk’s and Eli Lilly’s weight-loss drugs could drive demand
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
